Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6469209

COc1cc2nc(Nc3nc(O)c4cc(OCCN5CCCCC5)ccc4n3)nc(C)c2cc1OC.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RET P07949 2/20 0.43
KDR P35968 4/20 0.42
EGFR P00533 2/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
HRH3 Q9Y5N1 2/20 0.41
AVPR1B P47901 3/20 0.41
KCNH2 Q12809 1/20 0.41
ACHE P22303 1/20 0.40
CSF1R P07333 1/20 0.40
PDGFRB P09619 1/20 0.40
KIT P10721 1/20 0.40
FLT3 P36888 1/20 0.40
EHMT2 Q96KQ7 1/20 0.40
EHMT1 Q9H9B1 1/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL6469150 0.99 RET (0.42) RETKDREGFRESR1ESR2
Trifluoroacetic Acid SCHEMBL6468678 0.95 HRH3 (0.46) RETHRH3AVPR1BKCNH2EHMT2
Trifluoroacetic Acid SCHEMBL6471240 0.94 RET (0.43) RETKDREGFRAVPR1BEHMT2
Trifluoroacetic Acid SCHEMBL6470128 0.93 PDK1 (0.41) RETAVPR1BACHEEHMT2KDM4E
Trifluoroacetic Acid SCHEMBL6469283 0.91 HRH3 (0.39) RETEGFRHRH3EHMT2KDM4E
Trifluoroacetic Acid SCHEMBL6470902 0.89 HRH3 (0.42) KDRESR1ESR2HRH3AVPR1B
Trifluoroacetic Acid SCHEMBL6467099 0.89 RET (0.40) RETEGFRHRH3AVPR1BKCNH2
Trifluoroacetic Acid SCHEMBL6471255 0.89 RET (0.40) RETKDREGFRHRH3AVPR1B
SCHEMBL6469215 0.89 KDR (0.41) RETKDREGFRAVPR1BACHE
Trifluoroacetic Acid SCHEMBL6469094 0.88 WHR1 (0.37) PDGFRBEHMT2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB RET 4244/4885KDR 4703/4885EGFR 4458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.